UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 349

Sortiert nach

HIV pathogenesis: dynamics and genetics of viral populations and infected cells

Cold Spring Harbor perspectives in medicine, 2013-01, Vol.3 (1), p.a012526-a012526

2013

Volltextzugriff (PDF)

Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants

Journal of Virology, 2009-04, Vol.83 (8), p.3556-3567

2009

Volltextzugriff (PDF)

Macrophage Tropism of Human Immunodeficiency Virus Type 1 Isolates from Brain and Lymphoid Tissues Predicts Neurotropism Independent of Coreceptor Specificity

Journal of Virology, 2001-11, Vol.75 (21), p.10073-10089

2001

Volltextzugriff (PDF)

Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistance

Pharmacology & therapeutics (Oxford), 2000-05, Vol.86 (2), p.145-170

2000

Volltextzugriff (PDF)

HIV-1 populations can persist as active reservoirs in the CNS during ART treatment

Journal of Virus Eradication, 2017-12, Vol.3, p.25

2017

Volltextzugriff (PDF)

HIV-1 in the latent reservoir is largely sensitive to circulating T cells

Journal of Virus Eradication, 2019-12, Vol.5, p.43

2019

Volltextzugriff (PDF)

Development and characterization of a new single cycle vaccine vector in the simian immunodeficiency virus model system

Virology (New York, N.Y.), 2008-03, Vol.372 (1), p.72-84

2008

Volltextzugriff (PDF)

HIV-1 pathogenesis: the virus

Cold Spring Harbor perspectives in medicine, 2012-12, Vol.2 (12), p.a007443-a007443

2012

Volltextzugriff (PDF)

Compensatory Evolution in RNA Secondary Structures Increases Substitution Rate Variation among Sites

Molecular biology and evolution, 2008-08, Vol.25 (8), p.1778-1787

2008

Volltextzugriff (PDF)

Proteolytic Processing of the P2/Nucleocapsid Cleavage Site Is Critical for Human Immunodeficiency Virus Type 1 RNA Dimer Maturation

Journal of Virology, 2001-10, Vol.75 (19), p.9156-9164

2001

Volltextzugriff (PDF)

Defining the landscape of HIV-specific T-cell responses in HIV-1 infected durably suppressed participants

Journal of Virus Eradication, 2017-12, Vol.3, p.39

2017

Volltextzugriff (PDF)

The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency

Journal of Virology, 1994-10, Vol.68 (10), p.6782-6786

1994

Volltextzugriff (PDF)

V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability

Journal of Virology, 1993-09, Vol.67 (9), p.5623-5634

1993

Volltextzugriff (PDF)

The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions

Journal of Virology, 1994-12, Vol.68 (12), p.8017-8027

1994

Volltextzugriff (PDF)

Effects of Genital Tract Inflammation on Human Immunodeficiency Virus Type 1 V3 Populations in Blood and Semen

Journal of Virology, 2000-10, Vol.74 (19), p.8946-8952

2000

Volltextzugriff (PDF)

Postnatally-transmitted HIV-1 variants are efficient at dendritic cell trans-infection and sensitive to autologous and heterologous neutralization

Retrovirology, 2012-09, Vol.9 (S2), p.P148-P148, Article P148

2012

Volltextzugriff (PDF)

Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector

Journal of Virology, 1997-04, Vol.71 (4), p.3031-3038

1997

Volltextzugriff (PDF)

Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid

The Journal of biological chemistry, 1991-08, Vol.266 (22), p.14539-14547

1991

Volltextzugriff (PDF)

Dual-affinity re-targeting (DART) proteins overcome viral diversity to deplete the latent HIV-1 reservoir

Journal of Virus Eradication, 2015-12, Vol.1, p.18-18

2015

Volltextzugriff (PDF)

Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo

Journal of Virology, 1993-08, Vol.67 (8), p.4639-4650

1993

Volltextzugriff (PDF)

Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course

AIDS (London), 2009-05, Vol.23 (8), p.907-915

2009

Volltextzugriff (PDF)

A Strong Dominant Negative Mutation in the HIV-1 Gag Protein Defines a New Drug Target

Antiviral research, 2009-05, Vol.82 (2), p.A43-A43

Swanstrom, Ronald

2009

Volltextzugriff (PDF)

Improved Success of Phenotype Prediction of the Human Immunodeficiency Virus Type 1 from Envelope Variable Loop 3 Sequence Using Neural Networks

Virology (New York, N.Y.), 2001-09, Vol.288 (1), p.51-62

2001

Volltextzugriff (PDF)

Human Immunodeficiency Virus Type 1 Gag Proteins are Processed in Two Cellular Compartments

Proceedings of the National Academy of Sciences - PNAS, 1991-05, Vol.88 (10), p.4528-4532

1991

Volltextzugriff (PDF)

Patterns of Changes in Human Immunodeficiency Virus Type 1 V3 Sequence Populations Late in Infection

Journal of Virology, 2000-09, Vol.74 (18), p.8494-8501

2000

Volltextzugriff (PDF)

1 – 25 von 349

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(319)
Mit Volltextzugriff
(303)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(346)
Japanisch
(47)
Deutsch
(2)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(246)
Life Sciences & Biomedicine
(230)
Humans
(188)
Virology
(122)
Biological And Medical Sciences
(92)
Microbiology
(76)
Hiv-1 - Genetics
(63)
Female
(62)
Surgery
(57)
Human Immunodeficiency Virus 1
(56)
Animals
(55)
Medical Sciences
(55)
Aids/hiv
(52)
Male
(48)
Molecular Sequence Data
(48)
Fundamental And Applied Biological Sciences. Psychology
(46)
Human Immunodeficiency Virus
(46)
Hiv
(40)
Base Sequence
(39)
Immunology
(38)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

HIV pathogenesis: dynamics and genetics of viral populations and infected cells

Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants

Macrophage Tropism of Human Immunodeficiency Virus Type 1 Isolates from Brain and Lymphoid Tissues Predicts Neurotropism Independent of Coreceptor Specificity

Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistance

HIV-1 populations can persist as active reservoirs in the CNS during ART treatment

HIV-1 in the latent reservoir is largely sensitive to circulating T cells

Development and characterization of a new single cycle vaccine vector in the simian immunodeficiency virus model system

HIV-1 pathogenesis: the virus

Compensatory Evolution in RNA Secondary Structures Increases Substitution Rate Variation among Sites

Proteolytic Processing of the P2/Nucleocapsid Cleavage Site Is Critical for Human Immunodeficiency Virus Type 1 RNA Dimer Maturation

Defining the landscape of HIV-specific T-cell responses in HIV-1 infected durably suppressed participants

The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency

V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability

The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions

Effects of Genital Tract Inflammation on Human Immunodeficiency Virus Type 1 V3 Populations in Blood and Semen

Postnatally-transmitted HIV-1 variants are efficient at dendritic cell trans-infection and sensitive to autologous and heterologous neutralization

Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector

Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid

Dual-affinity re-targeting (DART) proteins overcome viral diversity to deplete the latent HIV-1 reservoir

Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo

Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course

A Strong Dominant Negative Mutation in the HIV-1 Gag Protein Defines a New Drug Target

Improved Success of Phenotype Prediction of the Human Immunodeficiency Virus Type 1 from Envelope Variable Loop 3 Sequence Using Neural Networks

Human Immunodeficiency Virus Type 1 Gag Proteins are Processed in Two Cellular Compartments

Patterns of Changes in Human Immunodeficiency Virus Type 1 V3 Sequence Populations Late in Infection

Suchergebnisse filtern